Keywords

#risankizumab

Risankizumab

Humanized monoclonal antibody

Risankizumab, sold under the brand name Skyrizi, is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, and Crohn's disease. It is designed to target interleukin 23A (IL-23A). It is given by subcutaneous injection.

Sat 6th

Provided by Wikipedia

Learn More

This keyword could refer to multiple things. Here are some suggestions:

Risankizumab Interleukin 23 Dupilumab Crohn's disease Psoriatic arthritis Psoriasis List of therapeutic monoclonal antibodies Avacincaptad pegol Boehringer Ingelheim Interleukin 1 beta
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.